about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmDeep vein thrombosis: current status and nanotechnology advances.Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease.Liposomes in diagnosis and treatment of cardiovascular disorders.Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.The glycocalyx of human, bovine and murine microvascular endothelial cells cultured in vitro.Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Targeted modulation of reactive oxygen species in the vascular endotheliumPolymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisEndothelial targeting of antibody-decorated polymeric filomicelles.Design of nanovectors for therapy and imaging of cardiovascular diseasesAntioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.Painting blood vessels and atherosclerotic plaques with an adhesive drug depotCollaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.Non-affinity factors modulating vascular targeting of nano- and microcarriersWhat is going on between defibrotide and endothelial cells? Snapshots reveal the hot spots of their romanceEngineering Factor Xa Inhibitor with Multiple Platelet-Binding Sites Facilitates its Platelet Targeting.Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium.Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.Standardization of models and methods used to assess nanoparticles in cardiovascular applications.Overcoming in vivo barriers to targeted nanodelivery.Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts.Dynamic factors controlling targeting nanocarriers to vascular endothelium.Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.Targeted interception of signaling reactive oxygen species in the vascular endotheliumChallenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology.Nanocarriers for vascular delivery of anti-inflammatory agentsNanomedicines in gastroenterology and hepatology.Interaction between drug delivery vehicles and cells under the effect of shear stress.The Future of Nanoparticle-Directed Venous Therapy.Targeting vascular (endothelial) dysfunction.The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases.Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactorEvaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement.Targeting delivery of drugs in the vascular system.Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation.
P2860
Q27026630-EBA83B60-2959-4FC2-B85E-578FC23731D1Q30369732-B02509C8-C9E1-4897-AE93-3E9613867B2DQ30414837-01C18A41-1E89-4052-A494-F293F15C51D0Q30464757-E3844FB6-DC37-4CD3-99A1-B691FCA7C78EQ30466992-C492A1D4-FEBE-44AD-B262-E8ADD56015A5Q33543619-33361AE0-5E92-4507-9B08-D66C03FF9797Q33812816-D215DE62-3E94-4C75-A071-4A3AA3447ACDQ34030709-9004426F-2EFA-40F0-8813-7F4630440FFDQ35098774-CF765D95-F049-453C-8020-CEBFF54F0F09Q35710262-C88F2015-EFB7-43A8-8B4F-DBF70BFEAECAQ35930068-EC32C732-A4B0-4725-8E1A-7615AA2101E5Q36119295-B90CF832-92CF-45A5-A71D-55518A41F056Q36392586-E5AC7614-E285-4A4A-9B00-5FB2BE1D9104Q36504186-45DAE584-7446-41B7-A4B1-BD74EC851AF7Q36601477-BDE35AC6-A3EE-4166-8743-852A6B34BA0AQ36703526-4E8D96CB-5429-4274-B3D1-B2CD514E0F98Q36755496-F1A8FDDE-AD58-450E-8B50-233DC1324FD5Q37105092-A4BC6393-BA34-4877-A541-BA7069BF55ABQ37326944-D39ABA80-26C6-4717-A71E-B52A50C2CE44Q37416891-BF63E435-6E47-4263-B526-06BBDBF67186Q37638947-B6A7F9FE-276F-44A6-BDEC-D5A339EC0D52Q37771030-8AE83888-2993-47C2-9DC6-8913CBD95BE1Q37804385-79528BF1-2B60-4161-A14C-B54AD5E80933Q37841416-833E78AE-007E-4F67-94F2-3CCF227C2544Q37871580-B1B0915E-889F-40E0-907A-595A46CEFFE4Q37902117-15CAEB39-E2C0-4733-9CB2-77E1749CC145Q37980236-C69F2580-9265-4FE8-B852-FA0B132C86ABQ38007992-08A48FB2-A4A4-483D-98A2-31DA52F1A8E7Q38029695-EDD96957-D7A0-4BAE-92C4-3B4FAA47C3D2Q38162098-02D7E90F-1339-4E56-B2C8-85762637EF5AQ38176037-F6086451-5D83-4618-A3D7-B977EA6301FBQ38370747-B979F52A-157A-4F88-89E4-4CA15880D38DQ38548252-5C57EC61-5F09-41E6-9C8B-159DBAD010CCQ38749932-0092D668-D964-4473-8B80-4EE3B0727891Q38836199-6051D8D2-FA64-4535-9EF0-F50F26F4697EQ38847912-82DEAFB5-5362-4830-B14C-F33C003E9685Q39061982-BEB7C2BF-0607-4FEE-B4C7-CB34C3EE087EQ39697051-93D62485-1E88-4619-84F8-F58B44D17A9BQ42120320-D333C78D-54F0-4F70-92A8-36C9D352597CQ42160647-A86D4FD9-F896-4380-8D32-A85B859217D8
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Targeted delivery of therapeutics to endothelium.
@ast
Targeted delivery of therapeutics to endothelium.
@en
type
label
Targeted delivery of therapeutics to endothelium.
@ast
Targeted delivery of therapeutics to endothelium.
@en
prefLabel
Targeted delivery of therapeutics to endothelium.
@ast
Targeted delivery of therapeutics to endothelium.
@en
P2093
P2860
P1476
Targeted delivery of therapeutics to endothelium.
@en
P2093
Bi-Sen Ding
Eric Simone
Vladimir Muzykantov
P2860
P2888
P304
P356
10.1007/S00441-008-0676-7
P577
2008-09-25T00:00:00Z
P5875
P6179
1003264266